Treace Medical Concepts, Inc. TMCI Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Treace Medical Concepts, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s accounts receivable?
- Treace Medical Concepts, Inc. (TMCI) reported accounts receivable of $30.36M in Q1 2026.
- How has Treace Medical Concepts, Inc.'s accounts receivable changed year-over-year?
- Treace Medical Concepts, Inc.'s accounts receivable decreased by 2.4% year-over-year, from $31.11M to $30.36M.
- What is the long-term trend for Treace Medical Concepts, Inc.'s accounts receivable?
- Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s accounts receivable has grown at a 27.8% compound annual growth rate (CAGR), from $51.2M to $136.56M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.